What is Animal Stem Cell Therapy Market?
Advances in the stem cell therapy sector have been phenomenal over the years. Its assistance in curing humans of various diseases and disorders has generated expansive advancements. These advancements are not just limited to humans. Stem cell therapy has also acquired a prominent place in the veterinary sector. Stem cell therapy is often referred to as regenerative medicine, a technique that enables the body to repair and regenerate damaged tissues. The animal stem cell therapy process involves three steps which include the collection of stem cell samples from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of inflammatory bowel, kidney, liver, heart, and immune-mediated diseases respectively.
The market study is being classified by Type (Dogs, Cats, Horses and Others), by Application (Osteoarthritis, Injuries to bones, Joints, Tendons, Ligament, Spinal cord and Others) and major geographies with country level break-up.
MediVet Biologic(United States), VETSTEM BIOPHARMA(United States), Gallant Pet (United States), Celavet(United States), Magellan Stem Cells (Australia), U.S. Stem Cell(United States), ANIMAL CELL THERAPIES(United States), Animal Care Stem(United States) and Cell Therapy Sciences(United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are VetCell Therapeutics (United States), Animacel (Slovenia) and Aratana Therapeutics (United States).
The animal stem cell therapy market can be described as mildly divided. With an extensive piece of players, the animal cell treatment market is encircled by significant competition. Innovative work exercises structure a significant piece of the development scene since they help acquire novel experiences. Activities such as mergers, consolidations, acquisitions, joint endeavors, coordinated efforts, and associations structure the establishment of the development of the animal stem cell therapy treatment market. These exercises assist makers with acquiring impact and in the end help in expanding the development pace of animal stem cell therapy in the market Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Animal Stem Cell Therapy market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Animal Stem Cell Therapy market by Type, Application and Region.
On the basis of geography, the market of Animal Stem Cell Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The growing adoption of pet animals and the rising number of veterinary and everyday pet care institutions is probably going to cultivate the development of the Animal Stem Cell Therapy market
- Increasing prevalence of diseases and disorders in animals
- Increasing emphasis on providing treatment without side-effects is contributing to the growth of the market
- Increased expenditure on animal health in many countries from all across the globe
- High cost associated with animal stem cell therapy
- Increasing Demand for Treatment of Animals
- Growing government funding and initiative for the protection of animals and fast approvals of FDA contributing towards the rapid growth of the animal stem cell therapy
- Lack of awareness regarding the treatment using Animal Stem Cell Therapy
Market Leaders and some development strategies
In July 2020 Boehringer Ingelheim German-based pharma organization reported gains GST to fortify its foundational microorganism abilities in Animal Health, unites with Belgian biotech organization GST which creates and delivers cutting edge undeveloped cell items for ponies and pets. The securing follows two years of a fruitful organization that brought the principal ever enlisted undeveloped cell-based veterinary medication to the European market. The choice to secure GST is completely lined up with part of Boehringer Ingelheim's Animal Health methodology, planning to reinforce its portfolio abilities to quicken advancement and development.
In October 2019 Gallant an animal biotech organization set to help pets live on with better and more joyful lives Launches Stem Cell Banking for Dogs Nationwide. The organization has built up the first and only non-obtrusive approach to gathering immature microorganisms, which have been utilized to treat sicknesses going from torn tendons to joint pain to kidney illness.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Animal Stem Cell Therapy provider, Government Regulatory and Research Organizations and End-Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase